|
Category:
Description:
Indications:
-
Moderate
to severe pain (surgical, cancer, burns)
-
Migraine
headache (nasal inhaler)
Contraindications:
Precautions:
-
Pregnancy
Category C
-
Patients
will experience CNS effects of drowsiness and dizziness, therefore use
caution with motor vehicle operation or other hazardous tasks.
-
Low
physical dependence, however use in caution with unstable or history
of abuse patients.
-
Avoid
prolonged, sustained usage to decrease addiction potential.
-
Geriatric
patients may have decreased medication clearance and elimination,
therefore dosage must be modified.
-
Use
with caution with other CNS depressive medications.
Adverse
Reactions (Side Effects):
|
Dosage:
Administered
by injection (IM or IV) or nasal inhalation, adjusted to severity of pain
Adult:
-
Initial
dose: 2mg IM or 1mg IV, repeated q3-4h as needed
-
Maintenance:
1-4mg IM or 0.5-2mg IV q3-4h
-
Inhalation:
1 spray (1mg per spray) in each nostril, if pain control not achieved
then repeat with one spray in one nostril in 60-90 minutes, then q3-4h
if needed
Geriatric
or Impaired Hepatic or Renal Function:
-
One-half
( ½ ) normal dose IM or IV
-
Inhalation:
1 spray (1mg per spray) in each nostril, if pain control not achieved
then repeat with one spray in one nostril in 90-120 minutes, then q6h
if needed
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks.
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|
